Live Breaking News & Updates on Janssen Pharmaceutical Cos

Stay updated with breaking news from Janssen pharmaceutical cos. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Johnson & Johnson's Janssen Pharma Touts Positive Results in Nipocalimab Phase 2 Trial

By Ben Glickman Johnson & Johnson said Monday that its drug, nipocalimab, had positive results in a Phase 2 clinical trial. The Spring House, Penn.-based. ....

Ben Glickman , Drug Administration , Spring House , Janssen Pharmaceutical Cos ,

Biomanufacturer planning $150M Boxborough facility


Arranta Bio, a microbiome contract development and manufacturing organization, is planning a $150-million facility in Boxborough to drastically increase its capacity beyond its sites in Watertown and Florida.
Arranta has begun work on the first phase of what will be a 130,000-square-foot biomanufacturing facility, a space so large it exceeds that of its two existing facilities combined. The company said it plans to employ more than 250 workers at the facility, with completion of the first phase set for early 2022.
As a so-called CDMO, Watertown-based Arranta provides manufacturing space for drug, life science or other products for clients. Before the Boxborough announcement, it had already invested more than $100 million last year to expand its supply capacity in helping microbiome firms. About 400 companies are actively exploring the links between diseases and the microbiome bacteria and viruses inside the body – in order to identify therapeutic targets, Arranta said. ....

United States , United Kingdom , Arranta Bio , Arranta Boxborough , Drug Administration , Bristol Myers Squibb , Watertown Based Arranta , Greater Boston , Janssen Pharmaceutical Cos , King Street Properties , Commonwealth Fusion Systems , ஒன்றுபட்டது மாநிலங்களில் , ஒன்றுபட்டது கிஂக்டம் , பிரிஸ்டல் மைஸ் ஸ்க்விப்ப் , அதிகமானது போஸ்டன் , ஜான்சன் மருந்து கோஸ் , கிங் தெரு ப்ராபர்டீஸ் , காமன்வெல்த் இணைவு அமைப்புகள் ,